TVTX
Travere Therapeutics, Inc.
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $651M | +19.9% |
| Gross profit | $641M | +20.1% |
| Operating income | −$133M | — |
| Net income | −$122M | — |
| EPS | −$1.28 | — |
| Free cash flow | −$281M2023 | — |
Travere Therapeutics, Inc.
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $651M | +19.9% |
| Gross profit | $641M | +20.1% |
| Operating income | −$133M | — |
| Net income | −$122M | — |
| EPS | −$1.28 | — |
| Free cash flow | −$281M2023 | — |